Encompass Health (NYSE: EHC) director gains 28 RSUs from dividend accrual

Rhea-AI Filing Summary

Encompass Health Corp director Greg D. Carmichael reported receiving 28 shares of Encompass Health common stock on January 15, 2026, recorded at a price of $0 per share as a stock-based award. Following this transaction, he beneficially owned 18,659 shares directly.

The filing explains that this award reflects additional restricted stock units credited to non-employee directors in connection with common stock dividend payments. On January 15, 2026, Encompass Health paid a $0.19 per share dividend when the stock’s closing price was $102.80, and the 28 RSUs reported are tied to that dividend-related accrual.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CARMICHAEL GREG D

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	01/15/2026		A		28(1)	A	$0	18,659	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Greg D. Carmichael	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Encompass Health (EHC) report for Greg D. Carmichael?

Greg D. Carmichael, a director of Encompass Health Corp, reported the acquisition of 28 shares of Encompass Health common stock on January 15, 2026, recorded at $0 per share as a stock-based award.

How many Encompass Health (EHC) shares does Greg D. Carmichael own after this Form 4 transaction?

After the reported transaction, Greg D. Carmichael beneficially owned 18,659 shares of Encompass Health common stock in direct ownership, according to the filing.

What triggered the 28-share award reported in this Encompass Health (EHC) Form 4?

The 28-share award reflects restricted stock units credited under non-employee director award agreements in connection with Encompass Health’s $0.19 per share common stock dividend paid on January 15, 2026.

How are restricted stock units (RSUs) calculated for Encompass Health (EHC) non-employee directors?

The number of RSUs credited is equal to the product of the RSUs in a director’s account on the dividend record date and the per share dividend, divided by the closing price on the dividend payment date, as described in the award agreements.

What stock price was used to calculate the RSUs in this Encompass Health (EHC) Form 4?

The calculation of additional restricted stock units used a closing price of $102.80 for Encompass Health common stock on the January 15, 2026 dividend payment date.

Is the Encompass Health (EHC) Form 4 transaction a cash purchase by the director?

No. The reported 28-share acquisition is described as an award of restricted stock units associated with a dividend payment and is recorded at $0 per share, rather than a cash purchase in the market.